Science In 1992: What Can We Do To Resolve The Uncertainties?

As The Scientist enters its sixth year of publication, it faces a task that its staffers and I engage with energy and optimism. We are determined to further the publication's success to date by continuing to provide a unique news and career information vehicle for all members of the science profession. Our optimism and energy stem, to a great extent, from our healthy 1991 performance as measured against two important periodical publishing benchmarks: circulation and advertising. During the p

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Our optimism and energy stem, to a great extent, from our healthy 1991 performance as measured against two important periodical publishing benchmarks: circulation and advertising. During the past year, when many other publishing efforts have fallen victim to these troubled economic times, The Scientist has succeeded in relation to its objectives. Indeed, while some consumer and specialized trade publications have suffered fatal declines in circulation and advertising, we have experienced significant gains in both areas.

We view our strength--and this is confirmed by the communications we receive from readers and advertisers--as a blend of several distinctive factors. We're the only newspaper exclusively addressed to science; the editorial staff is dedicated to writing clearly and with sound ethical motivation about the issues of concern to today's researchers; the focus of every item is pertinent in some way to the career considerations of all readers; and we are aware that good science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo